{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bromine-based analytical technique", "diosbulbin B", "hepatotoxicity", "metabolic activation", "protein covalent binding"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28805726", "DateCompleted": {"Year": "2018", "Month": "05", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "08", "Day": "14"}], "Language": ["eng"], "ELocationID": ["249", "10.3390/toxins9080249"], "Journal": {"ISSN": "2072-6651", "JournalIssue": {"Volume": "9", "Issue": "8", "PubDate": {"Year": "2017", "Month": "Aug", "Day": "14"}}, "Title": "Toxins", "ISOAbbreviation": "Toxins (Basel)"}, "ArticleTitle": "Chemical Identity of Interaction of Protein with Reactive Metabolite of Diosbulbin B In Vitro and In Vivo.", "Abstract": {"AbstractText": ["Diosbulbin B (DIOB), a hepatotoxic furan-containing compound, is a primary ingredient in <i>Dioscorea bulbifera</i> L., a common herbal medicine. Metabolic activation is required for DIOB-induced liver injury. Protein covalent binding of an electrophilic reactive intermediate of DIOB is considered to be one of the key mechanisms of cytotoxicity. A bromine-based analytical technique was developed to characterize the chemical identity of interaction of protein with reactive intermediate of DIOB. Cysteine (Cys) and lysine (Lys) residues were found to react with the reactive intermediate to form three types of protein modification, including Cys adduction, Schiff's base, and Cys/Lys crosslink. The crosslink showed time- and dose-dependence in animals given DIOB. Ketoconazole pretreatment decreased the formation of the crosslink derived from DIOB, whereas pretreatment with dexamethasone or buthionine sulfoximine increased such protein modification. These data revealed that the levels of hepatic protein adductions were proportional to the severity of hepatotoxicity of DIOB."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shenyang Pharmaceutical University, P.O. Box 21, 103 Wenhua Road, Shenyang 110016, Liaoning, China. kaiwang_2009@163.com."}, {"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. kaiwang_2009@163.com."}], "LastName": "Wang", "ForeName": "Kai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shenyang Pharmaceutical University, P.O. Box 21, 103 Wenhua Road, Shenyang 110016, Liaoning, China. lindo.ngju@163.com."}], "LastName": "Lin", "ForeName": "Dongju", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shenyang Pharmaceutical University, P.O. Box 21, 103 Wenhua Road, Shenyang 110016, Liaoning, China. xiucai1224@163.com."}], "LastName": "Guo", "ForeName": "Xiucai", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. wenlin2@uw.edu."}], "LastName": "Huang", "ForeName": "Wenlin", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shenyang Pharmaceutical University, P.O. Box 21, 103 Wenhua Road, Shenyang 110016, Liaoning, China. yingpeng1999@163.com."}], "LastName": "Peng", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Pharmaceutics of Guizhou Province, Guizhou Medical University, Guiyang 550004, Guizhou, China. zhengneu@yahoo.com."}, {"Identifier": [], "Affiliation": "Wuya College of Innovation, Shenyang Pharmaceutical University, P.O. Box 21, 103 Wenhua Road, Shenyang 110016, Liaoning, China. zhengneu@yahoo.com."}], "LastName": "Zheng", "ForeName": "Jiang", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Toxins (Basel)", "NlmUniqueID": "101530765", "ISSNLinking": "2072-6651"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, 4 or More Rings"}, {"RegistryNumber": "0", "NameOfSubstance": "Proteins"}, {"RegistryNumber": "20086-06-0", "NameOfSubstance": "diosbulbin B"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "K3Z4F929H6", "NameOfSubstance": "Lysine"}, {"RegistryNumber": "K848JZ4886", "NameOfSubstance": "Cysteine"}, {"RegistryNumber": "R9400W927I", "NameOfSubstance": "Ketoconazole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Activation, Metabolic"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cysteine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Heterocyclic Compounds, 4 or More Rings"}, {"QualifierName": [], "DescriptorName": "Ketoconazole"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lysine"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Microsomes, Liver"}, {"QualifierName": ["chemistry"], "DescriptorName": "Proteins"}], "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gao H., Kuroyanagi M., Wu L., Kawahara N., Yasuno T., Nakamura Y. Antitumorpromoting constituents from Dioscorea bulbifera L. in JB6 mouse epidermal cells. Biol. Pharm. Bull. 2002;25:1241\u20131243. doi: 10.1248/bpb.25.1241.", "ArticleIdList": ["10.1248/bpb.25.1241", "12230129"]}, {"Citation": "Zhang H., Yuan J. The progress of diosbulbin B research on pharmacology and Toxicology. Herald Med. 2009;28:490\u2013492."}, {"Citation": "Tang Y. The research of Dioscoreae bulbifera L. in clinical application. Chin. J. Chin. Mater. Med. 1995;20:435\u2013438."}, {"Citation": "Rasikari H.L., Leach D.N., Waterman P.G., Spooner-Hart R.N., Basta A.H., Banbury L.K., Winter K.M., Forster P.I. Cytotoxic clerodanediterpenes from Glossocaryacalcicola. Phytochemistry. 2005;66:2844\u20132850. doi: 10.1016/j.phytochem.2005.09.024.", "ArticleIdList": ["10.1016/j.phytochem.2005.09.024", "16289257"]}, {"Citation": "Li S., Iliya I.A., Deng J., Zhao S. Flavonoids and anthraquinone from Dioscorea bulbifera L. Chin. J. Chin. Mater. Med. 2000;25:159\u2013160.", "ArticleIdList": ["12212098"]}, {"Citation": "Gao H., Shui A., Chen Y., Zhang X., Wu L. The chemical compositions of Dioscorea bulbifera L. J. Shenyang Pharm. Univ. 2003;20:178\u2013180."}, {"Citation": "Grynberg N.F., Echevarria A., Lima J.E., Pamplona S.S., Pinto A.C., Maciel M.A. Antitumour activity of two 19-nor-clerodane diterpenes, trans-dehydrocrotonin and trans-crotonin, from Croton cajucara. Planta Med. 1999;65:687\u2013689. doi: 10.1055/s-1999-14042.", "ArticleIdList": ["10.1055/s-1999-14042", "10630105"]}, {"Citation": "Cifuente D.A., Borkowski E.J., Sosa M.E., Gianello J.C., Giordano O.S., Tonn C.E. Clerodanediterpenes from Baccharissagittalis: Insect antifeedant activity. Phytochemistry. 2002;61:899\u2013905. doi: 10.1016/S0031-9422(02)00437-5.", "ArticleIdList": ["10.1016/S0031-9422(02)00437-5", "12453514"]}, {"Citation": "Demetzos C., Dimas K., Hatziantoniou S., Anastasaki T., Angelopoulou D. Cytotoxic and anti-inflammatory activity of labdane and cis-clerodane type diterpenes. Planta Med. 2001;67:614\u2013618. doi: 10.1055/s-2001-17362.", "ArticleIdList": ["10.1055/s-2001-17362", "11582537"]}, {"Citation": "Teponno R.B., Tapondjou A.L., Gatsing D., Djoukeng J.D., Abou-Mansour E., Tabacchi R., Tane P., Stoekli-Evans H., Lontsi D. Bafoudiosbulbins A, and B, two anti-salmonellal clerodane diterpenoids from Dioscorea bulbifera L. var sativa. Phytochemistry. 2006;67:1957\u20131963. doi: 10.1016/j.phytochem.2006.06.019.", "ArticleIdList": ["10.1016/j.phytochem.2006.06.019", "16876211"]}, {"Citation": "Niu Z., Chen A. 16 cases report of toxic hepatitis caused by Dioscorea bulbifera. Chin. J. Integr. Tradit. West. Liver Dis. 1994;4:55\u201356."}, {"Citation": "Yang H., Li J., Cui X., Yang C., Li L., Liu J. Clinical use and adverse drug reaction of compound prescription of Dioscorea bulbifera L. in clinical trial. Clin. Misdiagn. Misther. 2006;19:85\u201387."}, {"Citation": "Liu J. Two cases of toxic hepatitis caused by Dioscorea bulbifera L. Advers. Drug React. 2002;2:129\u2013130."}, {"Citation": "Wang J., Liang Q., Ji L., Liu H., Wang C., Wang Z. Gender-related difference in liver injury induced by Dioscorea. bulbifera L. rhizome in mice. Hum. Exp. Toxicol. 2010;30:1333\u20131341. doi: 10.1177/0960327110389926.", "ArticleIdList": ["10.1177/0960327110389926", "21075805"]}, {"Citation": "Ma Y., Niu C., Wang J., Ji L., Wang Z. Diosbulbin B-induced liver injury in mice and its mechanism. Hum. Exp. Toxicol. 2013;33:729\u2013736. doi: 10.1177/0960327113506232.", "ArticleIdList": ["10.1177/0960327113506232", "24107456"]}, {"Citation": "Li W., Lin D., Gao H., Xu Y., Meng D., Smith C.V., Peng Y., Zheng J. Metabolic activation of furan moiety makes diosbulbin B hepatotoxic. Arch. Toxicol. 2016;90:863\u2013872. doi: 10.1007/s00204-015-1495-8.", "ArticleIdList": ["10.1007/s00204-015-1495-8", "25851819"]}, {"Citation": "Byrns M.C., Predecki D.P., Peterson L.A. Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 2002;15:373\u2013379. doi: 10.1021/tx0101402.", "ArticleIdList": ["10.1021/tx0101402", "11896685"]}, {"Citation": "Chen L., Hecht S.S., Peterson L.A. Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 1997;10:866\u2013874. doi: 10.1021/tx9700174.", "ArticleIdList": ["10.1021/tx9700174", "9282835"]}, {"Citation": "Gates L.A., Lu D., Peterson L.A. Trapping of cis-2-butene-1,4-dial to measure furan metabolism in human liver microsomes by cytochrome P450 enzymes. Drug Metab. Dispos. 2012;40:596\u2013601. doi: 10.1124/dmd.111.043679.", "ArticleIdList": ["10.1124/dmd.111.043679", "PMC3286269", "22187484"]}, {"Citation": "Lu D., Peterson L.A. Identification of furan metabolites derived from cysteine cis-2-butene-1,4-dial-lysine crosslinks. Chem. Res. Toxicol. 2010;23:142\u2013151. doi: 10.1021/tx9003215.", "ArticleIdList": ["10.1021/tx9003215", "PMC2826838", "20043645"]}, {"Citation": "Lin D., Li C., Peng Y., Gao H., Zheng J. Cytochrome P450-mediated metabolic activation of diosbulbin B. Drug. Metab. Dispos. 2014;42:1727\u20131736. doi: 10.1124/dmd.114.059261.", "ArticleIdList": ["10.1124/dmd.114.059261", "25024403"]}, {"Citation": "Li C., Lin D., Gao H., Hua H., Peng Y., Zheng J. N-Acetyl lysine/glutathione-derived pyrroles as potential Ex Vivo biomarkers of bioactivated furan-containing compounds. Chem. Res. Toxicol. 2015;28:384\u2013393. doi: 10.1021/tx500334m.", "ArticleIdList": ["10.1021/tx500334m", "25489969"]}, {"Citation": "Yang B., Liu W., Chen K., Wang Z., Wang C. Metabolism of diosbulbin B in vitro and in vivo in rats: Formation of reactive metabolites and human enzymes involved. Drug Metab. Dispos. 2015;42:1737\u20131750. doi: 10.1124/dmd.114.058222.", "ArticleIdList": ["10.1124/dmd.114.058222", "25053620"]}, {"Citation": "Phillips M.B., Sullivan M.M., Villalta P.W., Peterson L.A. Covalent modification of cytochrome c by reactive metabolites of furan. Chem. Res. Toxicol. 2013;27:129\u2013135. doi: 10.1021/tx400368r.", "ArticleIdList": ["10.1021/tx400368r", "PMC3908668", "24364757"]}, {"Citation": "Moro S., Chipman J.K., Antczak P., Turan N., Dekant W., Falciani F., Mally A. Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity. Toxicol. Sci. 2012;126:336\u2013352. doi: 10.1093/toxsci/kfs005.", "ArticleIdList": ["10.1093/toxsci/kfs005", "22240984"]}, {"Citation": "Khojasteh S.C., Hartley D.P., Ford K.A., Uppal H., Oishi S., Nelson S.D. Characterization of rat liver proteins adducted by reactive metabolites of menthofuran. Chem. Res. Toxicol. 2012;25:2301\u20132309. doi: 10.1021/tx300144d.", "ArticleIdList": ["10.1021/tx300144d", "23106769"]}, {"Citation": "Wang K., Li W., Chen J., Peng Y., Zheng J. Detection of cysteine- and lysine-based protein adductions by reactive metabolites of 2,5-dimethylfuran. Anal. Chim. Acta. 2015;896:93\u2013101. doi: 10.1016/j.aca.2015.09.017.", "ArticleIdList": ["10.1016/j.aca.2015.09.017", "26481992"]}, {"Citation": "Wang K., Zheng L., Peng Y., Song J., Zheng J. Selective and sensitive platform for function-based screening of potentially harmful furans. Anal. Chem. 2014;86:10755\u201310762. doi: 10.1021/ac502796x.", "ArticleIdList": ["10.1021/ac502796x", "25279953"]}, {"Citation": "Kawasaki T., Komori T., Setoguchi S. Furanoidnorditerpenes from Dioscoreacae plants. 1. Diosbulins A, B, and C from Dioscorea. bulbifera form a spontanea. Chem. Pharm. Bull. 1968;16:2430\u20132435. doi: 10.1248/cpb.16.2430.", "ArticleIdList": ["10.1248/cpb.16.2430"]}, {"Citation": "Lin G., Tang J., Liu X., Jiang Y., Zheng J. Deacetylclivorine: A gender-selective metabolite of clivorine formed in female Sprague-Dawley rat liver microsomes. Drug Metab. Dispos. 2007;35:607\u2013613. doi: 10.1124/dmd.106.014100.", "ArticleIdList": ["10.1124/dmd.106.014100", "17237157"]}, {"Citation": "Jin H., Li L., Zhong D., Liu J., Chen X., Zheng J. Pulmonary toxicity and metabolic activation of tetrandrine in CD-1 mice. Chem. Res. Toxicol. 2011;24:2142\u20132152. doi: 10.1021/tx200290s.", "ArticleIdList": ["10.1021/tx200290s", "21992520"]}, {"Citation": "Jin H., Shen S., Chen X., Zhong D., Zheng J. CYP3A-mediated apoptosis of dauricine in cultured human bronchial epithelial cells and in lungs of CD-1 mice. Toxicol. Appl. Pharmacol. 2012;261:248\u2013254. doi: 10.1016/j.taap.2012.03.025.", "ArticleIdList": ["10.1016/j.taap.2012.03.025", "22521607"]}, {"Citation": "Lin H., Zhang H., Jushchyshyn M., Hollenberg P.F. Covalent modification of Thr302 in cytochrome P450 2B1 by the mechanism-based inactivator 4-tertbutylphenylacetylene. J. Pharmacol. Exp. Ther. 2010;333:663\u2013669. doi: 10.1124/jpet.109.164350.", "ArticleIdList": ["10.1124/jpet.109.164350", "PMC2879930", "20200115"]}, {"Citation": "Aloysius H., Tong V.W., Yabut J., Bradley S.A., Shang J., Zou Y., Tschirret-Guth R.A. Metabolic activation and major protein target of a 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonist. Chem. Res. Toxicol. 2012;25:1412\u20131422. doi: 10.1021/tx300017s.", "ArticleIdList": ["10.1021/tx300017s", "22765480"]}, {"Citation": "Taber D.F., DeMatteo P.W., Hassan R.A. Simplified Preparation of Dimethyldioxirane (DMDO) Org. Synth. 2013;90:350\u2013357."}]}], "History": [{"Year": "2017", "Month": "7", "Day": "10"}, {"Year": "2017", "Month": "7", "Day": "24"}, {"Year": "2017", "Month": "7", "Day": "28"}, {"Year": "2017", "Month": "8", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["28805726", "PMC5577583", "10.3390/toxins9080249", "toxins9080249"]}}]}